Overslaan en naar de inhoud gaan

 Wetenschapelijke artikelen

Vulnerabilities in Older Patients when Cancer Treatment is Initiated: Does a Cognitive Impairment Impact the Two-Year Survival?

Auteurs : Libert Y, Dubruille S, Borghgraef C, Etienne AM, Merckaert I, Paesmans M, Reynaert C, Roos M, Slachmuylder JL, Vandenbossche S, Bron D, Razavi D
Jaar : 2016
Journal : PLoS One
Volume : 11
Pagina's : e0159734

Results of the Belgian expanded access program of eribulin in the treatment of metastatic breast cancer closely mirror those of the pivotal phase III trial.

Auteurs : Aftimos P, Polastro L, Ameye L, Jungels C, Vakili J, Paesmans M, van den Eerenbeemt J, Buttice A, Gombos A, de Valeriola D, Gil T, Piccart-Gebhart M, Awada A
Jaar : 2016
Journal : Eur J Cancer
Volume : 60
Pagina's : 117-124

The Glasgow inflammatory score and lung cancer: A predictor of admissions to emergency units].

Auteurs : Gorham J, Ameye L, Paesmans M, Berghmans T, Sculier JP, Meert AP
Jaar : 2016
Journal : Rev Mal Respir
Volume : 33(9)
Pagina's : 759-65

Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis.

Auteurs : Phillips RS, Sung L, Amman RA, Riley RD, Castagnola E, Haeusler GM, Klaassen R, Tissing WJ, Lehrnbecher T, Chisholm J, Hakim H, Ranasinghe N, Paesmans M, Hann IM, Stewart LA
Jaar : 2016
Journal : Br J Cancer
Volume : 114
Pagina's : 623-630

Improved Survival of Calreticulin-Mutated Patients Compared With Janus Kinase 2 in Primary Myelofibrosis: A Meta-Analysis.

Auteurs : Kourie HR, Ameye L, Paesmans M, Bron D
Jaar : 2016
Journal : Clin Lymphoma Myeloma Leuk
Volume : 16(5)
Pagina's : 264-8

The current use and attitudes towards tumor genome sequencing in breast cancer.

Auteurs : Gingras I, Sonnenblick A, de Azambuja E, Paesmans M, Delaloge S, Aftimos P, Piccart-Gebhart M, Sotiriou C, Ignatiadis M, Azim HA Jr
Jaar : 2016
Journal : Sci Rep
Volume : 6
Pagina's : 22517

Difficulties and limitations in conducting translational research in thoracic oncology. A practical example.

Auteurs : Meert AP, Ameye L, Leclercq N, Paesmans M, Remmelink M, Sculier JP, Berghmans T
Jaar : 2016
Journal : Rev Mal Respir
Volume : 33(7)
Pagina's : 594-9

Results of a comparative analysis of magnetic resonance imaging-targeted versus three-dimensional transrectal ultrasound prostate biopsies: Size does matter.

Auteurs : Peltier A, Aoun F, Albisinni S, Marcelis Q, Ledinh D, Paesmans M, Lemort M, Van Velthoven R
Jaar : 2016
Journal : Scand J Urol
Volume : 50(3)
Pagina's : 144-8

Menopausal hormone therapy use in relation to breast cancer incidence in 11 European countries.

Auteurs : Antoine C, Ameye L, Paesmans M, de Azambuja E, Rozenberg S
Jaar : 2016
Journal : Maturitas
Volume : 84
Pagina's : 81-8

A Phase II trial evaluating the efficacy of sorafenib (BAY 43-9006) and correlating early FDG PET-CT response to outcome in patients with recurrent and/or metastatic head and neck cancer.

Auteurs : Lalami Y, Garcia C, Flamen P, Ameye L, Paesmans M, Awada A
Jaar : 2016
Journal : Head Neck
Volume : 38(3)
Pagina's : 347-54

Should the treatment of advanced lepidic adenocarcinoma be adapted to the pathological subtype?

Auteurs : Paesmans M
Jaar : 2015
Journal : Eur Respir J
Volume : 46
Pagina's : 1259-61

Primary tumour standardised uptake value is prognostic in nonsmall cell lung cancer: a multivariate pooled analysis of individual data.

Auteurs : Paesmans M, Garcia C, Wong CY, Patz EF Jr, Komaki R, Eschmann S, Govindan R, Vansteenkiste J, Meert AP, de Jong WK, Altorki NK, Higashi K, Van Baardwijk A, Borst GR, Ameye L, Lafitte JJ, Berghmans T, Flamen P, Rami-Porta R, Sculier JP
Jaar : 2015
Journal : Eur Respir J
Volume : 46
Pagina's : 1751-61

The Prognostic Significance of Metabolic Response Heterogeneity in Metastatic Colorectal Cancer.

Auteurs : Hendlisz A, Deleporte A, Delaunoit T, Maréchal R, Peeters M, Holbrechts S, Van den Eynde M, Houbiers G, Filleul B, Van Laethem JL, Ceyssens S, Barbuto AM, Lhommel R, Demolin G, Garcia C, El Mansy H, Ameye L, Moreau M, Guiot T, Paesmans M, Piccart-Gebhart M, Flamen P
Jaar : 2015
Journal : PLoS One
Volume : 10
Pagina's : e0138341

Implementation of an oncological care program in a multidisciplinary clinic.

Auteurs : Sculier JP, Leclercq N, Meert AP, Paesmans M, Berghmans T
Jaar : 2015
Journal : Rev Mal Respir

Cardiac assessment of early breast cancer patients 18years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy.

Auteurs : de Azambuja E, Ameye L, Diaz M, Vandenbossche S, Aftimos P, Hernández SB, Shih-Li C, Delhaye F, Focan C, Cornez N, Vindevoghel A, Beauduin M, Lemort M, Paesmans M, Suter T, Piccart-Gebhart M
Jaar : 2015
Journal : Eur J Cancer
Volume : 51
Pagina's : 2517-24

Epidemiology and Outcome of Fungemia in a Cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031).

Auteurs : Cornely OA, Gachot B, Akan H, Bassetti M, Uzun O, Kibbler C, Marchetti O, de Burghgraeve P, Ramadan S, Pylkkanen L, Ameye L, Paesmans M, Donnelly JP
Jaar : 2015
Journal : Clin Infect Dis
Volume : 61(3)
Pagina's : 324-31

Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol.

Auteurs : Hendlisz A, Deleporte A, Vandeputte C, Charette N, Paesmans M, Guiot T, Garcia C, Flamen P
Jaar : 2015
Journal : BMJ Open
Volume : 5(3)
Pagina's : e007189

Erratum: Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study.

Auteurs : Hendlisz A, Golfinopoulos V, Deleporte A, Paesmans M, El Mansy H, Garcia C, Peeters M, Annemans L, Vandeputte C, Maetens M, Van den Eynde M, Maréchal R, Borbath I, Dresse D, Houbiers G, Fried M, Awada A, Piccart-Gebhart M, Van Laethem JL, Flamen P
Jaar : 2015
Journal : BMC Cancer
Volume : 15
Pagina's : 173

MRI-Targeted Biopsies versus Systematic Transrectal Ultrasound Guided Biopsies for the Diagnosis of Localized Prostate Cancer in Biopsy Naïve Men.

Auteurs : Peltier A, Aoun F, Lemort M, Kwizera F, Paesmans M, Van Velthoven R
Jaar : 2015
Journal : Biomed Res Int
Volume : 2015(null)
Pagina's : 571708

Prospective Validation Obtained in a Similar Group of Patients and with Similar High Throughput Biological Tests Failed to Confirm Signatures for Prediction of Response to Chemotherapy and Survival in Advanced NSCLC: A Prospective Study from the Euro

Auteurs : Berghmans T, Ameye L, Lafitte JJ, Colinet B, Cortot A, CsToth I, Holbrechts S, Lecomte J, Mascaux C, Meert AP, Paesmans M, Richez M, Scherpereel A, Tulippe C, Willems L, Dernies T, Leclercq N, Sculier JP
Jaar : 2015
Journal : Front Oncol
Volume : 4
Pagina's : article 386 (1-16)